{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:37:33Z","timestamp":1758040653167,"version":"3.44.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.amjmed.2022.03.019","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T06:36:02Z","timestamp":1648708562000},"page":"828-835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Top Myths of Diagnosis and Management of Infectious Diseases in Hospital Medicine"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6606-9460","authenticated-orcid":false,"given":"Melissa D.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelina P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April P.","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Shaefer","family":"Spires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth Dodds","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjmed.2022.03.019_bib0001","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.2007","article-title":"Assessment of the appropriateness of antimicrobial use in US hospitals","volume":"4","author":"Magill","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.amjmed.2022.03.019_bib0002","first-page":"194","article-title":"Vital signs: improving antibiotic use among hospitalized patients","volume":"63","author":"Fridkin","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1016\/j.amjmed.2022.03.019_bib0003","doi-asserted-by":"crossref","first-page":"e4499","DOI":"10.1093\/cid\/ciaa1372","article-title":"Antibiotic overuse after hospital discharge: a multi-hospital cohort study","volume":"73","author":"Vaughn","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.amjmed.2022.03.019_bib0004","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1017\/ice.2016.276","article-title":"An evaluation of antibiotic prescribing practices upon hospital discharge","volume":"38","author":"Scarpato","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"10.1016\/j.amjmed.2022.03.019_bib0005","doi-asserted-by":"crossref","first-page":"ofab399","DOI":"10.1093\/ofid\/ofab399","article-title":"ADD It Up: an evaluation of antibiotic duration at hospital discharge at a community hospital","volume":"8","author":"Conner","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"10.1016\/j.amjmed.2022.03.019_bib0006","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11606-017-4099-6","article-title":"Categorical risk perception drives variability in antibiotic prescribing in the emergency department: a mixed methods observational study","volume":"32","author":"Klein","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"20","key":"10.1016\/j.amjmed.2022.03.019_bib0007","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2016.16201","article-title":"Us emergency department visits for outpatient adverse drug events, 2013-2014","volume":"316","author":"Shehab","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.amjmed.2022.03.019_bib0008","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of adverse events with antibiotic use in hospitalized patients","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jinf.2016.04.008","article-title":"Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia","volume":"73","author":"Chalmers","year":"2016","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.amjmed.2022.03.019_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jac\/dkx374","article-title":"Association between prior antibiotic therapy and subsequent risk of community-acquired infections: a systematic review","volume":"73","author":"Malik","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.amjmed.2022.03.019_bib0011","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.amjmed.2022.03.019_bib0012","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1017\/ice.2016.292","article-title":"Clinical risk score for prediction of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in bloodstream isolates","volume":"38","author":"Augustine","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"10.1016\/j.amjmed.2022.03.019_bib0013","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/cix947","article-title":"Risk of subsequent sepsis within 90 days after a hospital stay by type of antibiotic exposure","volume":"66","author":"Baggs","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.amjmed.2022.03.019_bib0014","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1086\/526535","article-title":"The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and Clostridium difficile","volume":"46","author":"Rice","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.amjmed.2022.03.019_bib0015","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"issue":"2 Pt 1","key":"10.1016\/j.amjmed.2022.03.019_bib0016","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1164\/ajrccm.162.2.9909095","article-title":"Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription","volume":"162","author":"Singh","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.amjmed.2022.03.019_bib0017","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamainternmed.2016.3646","article-title":"The new antibiotic mantra-\u201cShorter Is Better","volume":"176","author":"Spellberg","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.amjmed.2022.03.019_bib0018","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2146\/ajhp090360","article-title":"Is double coverage of gram-negative organisms necessary?","volume":"68","author":"SJ","year":"2011","journal-title":"Am J Health Syst Pharm"},{"issue":"10","key":"10.1016\/j.amjmed.2022.03.019_bib0019","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1086\/678066","article-title":"Economic impact of redundant antimicrobial therapy in US hospitals","volume":"35","author":"Schultz","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.amjmed.2022.03.019_bib0020","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/jac\/dks074","article-title":"Double trouble: how big a problem is redundant anaerobic antibiotic coverage in Veterans Affairs medical centres?","volume":"67","author":"Huttner","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.amjmed.2022.03.019_bib0021","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.amjmed.2022.03.019_bib0022","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.amjmed.2022.03.019_bib0023","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.amjmed.2022.03.019_bib0024","unstructured":"National Comprehensive Cancer Network. Prevention and treatment of cancer-related infections. 2021. Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=3&id=1457. Accessed January 4, 2022."},{"issue":"3","key":"10.1016\/j.amjmed.2022.03.019_bib0025","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.amjmed.2022.03.019_bib0026","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.2020.0103","article-title":"Effect of vancomycin or daptomycin with vs without an antistaphylococcal \u03b2-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial","volume":"323","author":"Tong","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.amjmed.2022.03.019_bib0027","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/jama.2019.21472","article-title":"Combination therapy for methicillin-resistant Staphylococcus aureus bacteremia: not ready for prime time","volume":"323","author":"Gandhi","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amjmed.2022.03.019_bib0028","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/0976-500X.130042","article-title":"Switch over from intravenous to oral therapy: a concise overview","volume":"5","author":"Cyriac","year":"2014","journal-title":"J Pharmacol Pharmacother"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0029","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jac\/dkp131","article-title":"Outcomes of early switching from intravenous to oral antibiotics on medical wards","volume":"64","author":"Mertz","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.amjmed.2022.03.019_bib0030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjmed.2022.03.019_bib0031","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jamainternmed.2020.0555","article-title":"Evaluation of a paradigm shift from intravenous antibiotics to oral step-down therapy for the treatment of infective endocarditis: a narrative review","volume":"180","author":"Spellberg","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.amjmed.2022.03.019_bib0032","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.20166","article-title":"Oral \u03b2-lactam antibiotics vs fluoroquinolones or trimethoprim-sulfamethoxazole for definitive treatment of Enterobacterales bacteremia from a urine source","volume":"3","author":"Sutton","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.amjmed.2022.03.019_bib0033","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/jac\/dkab271","article-title":"Fully oral targeted antibiotic therapy for Gram-positive cocci-related periprosthetic joint infections: a real-life before and after study","volume":"76","author":"Coehlo","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.amjmed.2022.03.019_bib0034","doi-asserted-by":"crossref","first-page":"e01515","DOI":"10.1128\/AAC.01515-20","article-title":"Fluoroquinolone versus beta-lactam oral step-down therapy for uncomplicated streptococcal bloodstream infections","volume":"64","author":"Arensman","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.amjmed.2022.03.019_bib0035","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1093\/cid\/ciy1121","article-title":"Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America","volume":"68","author":"Nicolle","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0036","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.idc.2013.09.005","article-title":"Approach to a positive urine culture in a patient without urinary symptoms","volume":"28","author":"Trautner","year":"2014","journal-title":"Infect Dis Clin North Am"},{"issue":"8","key":"10.1016\/j.amjmed.2022.03.019_bib0037","article-title":"Antibiotics for asymptomatic bacteriuria in pregnancy","author":"Smaill","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0038","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1017\/ash.2021.167","article-title":"Deconstructing the urinalysis: a novel approach to diagnostic and antimicrobial stewardship","volume":"1","author":"Advani","year":"2021","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.03.019_bib0039","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.idc.2017.07.002","article-title":"Urinary tract infection and asymptomatic bacteriuria in older adults","volume":"31","author":"Cortes-Penfield","year":"2017","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.amjmed.2022.03.019_bib0040","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3122\/jabfm.2011.04.100007","article-title":"Urine clarity inaccurate to rule out urinary tract infection in women","volume":"24","author":"Foley","year":"2011","journal-title":"J Am Board Fam Med"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0041","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jemermed.2016.02.009","article-title":"Top ten myths regarding the diagnosis and treatment of urinary tract infections","volume":"51","author":"Schulz","year":"2016","journal-title":"J Emerg Med"},{"issue":"4","key":"10.1016\/j.amjmed.2022.03.019_bib0042","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cmi.2020.10.001","article-title":"Antibiotic susceptibility reporting and association with antibiotic prescribing: a cohort study","volume":"27","author":"Langford","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0043","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jhin.2020.06.016","article-title":"Point prevalence of penicillin allergy in hospital inpatients","volume":"106","author":"Baxter","year":"2020","journal-title":"J Hosp Infect"},{"issue":"6","key":"10.1016\/j.amjmed.2022.03.019_bib0044","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jhm.2036","article-title":"The impact of penicillin skin testing on clinical practice and antimicrobial stewardship","volume":"8","author":"Rimawi","year":"2013","journal-title":"J Hosp Med"},{"issue":"3","key":"10.1016\/j.amjmed.2022.03.019_bib0045","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: A cohort study","volume":"133","author":"Macy","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"10167","key":"10.1016\/j.amjmed.2022.03.019_bib0046","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.amjmed.2022.03.019_bib0047","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1034\/j.1398-9995.2002.23700.x","article-title":"Oral antibiotic adverse reactions after penicillin skin testing: multi-year follow-up","volume":"57","author":"Macy","year":"2002","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.amjmed.2022.03.019_bib0048","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/all.13168","article-title":"Clinical outcomes following inpatient penicillin allergy testing: A systematic review and meta-analysis","volume":"72","author":"Sacco","year":"2017","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0049","doi-asserted-by":"crossref","first-page":"dlaa123","DOI":"10.1093\/jacamr\/dlaa123","article-title":"Safety and efficacy of de-labelling penicillin allergy in adults using direct oral challenge: a systematic review","volume":"3","author":"Cooper","year":"2021","journal-title":"JAC Antimicrob Resist"},{"issue":"5","key":"10.1016\/j.amjmed.2022.03.019_bib0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.9820","article-title":"Evaluation of a Pharmacist-Led Penicillin Allergy Assessment Program and Allergy Delabeling in a Tertiary Care Hospital","volume":"4","author":"Turner","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0051","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13223-020-00494-2","article-title":"Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology","volume":"16","author":"Jeimy","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"8","key":"10.1016\/j.amjmed.2022.03.019_bib0052","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","article-title":"Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017","volume":"152","author":"Berr\u00edos-Torres","year":"2017","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.amjmed.2022.03.019_bib0053","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1445-2197.1998.tb04785.x","article-title":"Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review","volume":"68","author":"McDonald","year":"1998","journal-title":"Aust N Z J Surg"},{"issue":"7","key":"10.1016\/j.amjmed.2022.03.019_bib0054","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/jamasurg.2019.0569","article-title":"Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events","volume":"154","author":"Branch-Elliman","year":"2019","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/sur.2013.9999","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"14","author":"Bratzler","year":"2013","journal-title":"Surg Infect"},{"issue":"25","key":"10.1016\/j.amjmed.2022.03.019_bib0056","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1161\/01.CIR.101.25.2916","article-title":"Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance","volume":"101","author":"Harbarth","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.amjmed.2022.03.019_bib0057","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/hrt.70.6.585","article-title":"Antibiotic prophylaxis for cardiac surgery: current United Kingdom practice","volume":"70","author":"Parry","year":"1993","journal-title":"Br Heart J"},{"issue":"5","key":"10.1016\/j.amjmed.2022.03.019_bib0058","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/SAP.0b013e31820c0593","article-title":"Current practice among plastic surgeons of antibiotic prophylaxis and closed-suction drains in breast reconstruction: experience, evidence, and implications for postoperative care","volume":"66","author":"Phillips","year":"2011","journal-title":"Ann Plast Surg"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0059","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.athoracsur.2005.06.034","article-title":"The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration","volume":"81","author":"Edwards","year":"2006","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0060","doi-asserted-by":"crossref","first-page":"e2613","DOI":"10.1097\/GOX.0000000000002613","article-title":"Extended prophylactic antibiotics for mastectomy with immediate breast reconstruction: a meta-analysis","volume":"8","author":"Hai","year":"2020","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0061","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12028-015-0224-8","article-title":"The insertion and management of external ventricular drains: an evidence-based consensus statement: a statement for healthcare professionals from the Neurocritical Care Society","volume":"24","author":"Fried","year":"2016","journal-title":"Neurocrit Care"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.019_bib0062","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1345\/aph.1R352","article-title":"Nitrofurantoin contraindication in patients with a creatinine clearance below 60 mL\/min: looking for the evidence","volume":"47","author":"Oplinger","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"9","key":"10.1016\/j.amjmed.2022.03.019_bib0063","doi-asserted-by":"crossref","first-page":"ofab442","DOI":"10.1093\/ofid\/ofab442","article-title":"Retrospective review on the safety and efficacy of nitrofurantoin for the treatment of cystitis in the veteran population with or without renal insufficiency","volume":"8","author":"Welch","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.amjmed.2022.03.019_bib0064","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10096-017-2911-1","article-title":"Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications","volume":"36","author":"Cunha","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.amjmed.2022.03.019_bib0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3821\/1913-701X-142.5.248","article-title":"A retrospective review assessing the efficacy and safety of nitrofurantoin in renal impairment","volume":"142","author":"Bains","year":"2009","journal-title":"Can Pharm J"},{"issue":"4","key":"10.1016\/j.amjmed.2022.03.019_bib0066","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/jgs.14072","article-title":"Evaluation of the risk of nitrofurantoin lung injury and its efficacy in diminished kidney function in older adults in a large integrated healthcare system: a matched cohort study","volume":"64","author":"Santos","year":"2016","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.amjmed.2022.03.019_bib0067","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1756287215581556","article-title":"Effectiveness and safety of nitrofurantoin in outpatient male veterans","volume":"7","author":"Ingalsbe","year":"2015","journal-title":"Ther Adv Urol"},{"issue":"10","key":"10.1016\/j.amjmed.2022.03.019_bib0068","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.cmi.2020.03.001","article-title":"The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function","volume":"26","author":"Ten Doesschate","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.amjmed.2022.03.019_bib0069","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjmed.2022.03.019_bib0070","unstructured":"U.S. Food & Drug Administration (FDA). FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. Available at:https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-reinforces-safety-information-about-serious-low-blood-sugar-levels-and-mental-health-side. Accessed November 29, 2021."},{"key":"10.1016\/j.amjmed.2022.03.019_bib0071","unstructured":"U.S. Food & Drug Administration (FDA). FDA Drug Safety Communication: FDA requires label changes to warn of risk for possibly permanent nerve damage from antibacterial fluoroquinolone drugs taken by mouth or by injection. Available at:http:\/\/wayback.archive-it.org\/7993\/20170112031629\/http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm365050.htm. Accessed November 29, 2021."},{"key":"10.1016\/j.amjmed.2022.03.019_bib0072","unstructured":"U.S. Food & Drug Administration (FDA). FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. Available at:https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-advises-restricting-fluoroquinolone-antibiotic-use-certain. Accessed November 29, 2021."},{"key":"10.1016\/j.amjmed.2022.03.019_bib0073","unstructured":"U.S. Food & Drug Administration (FDA). FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. Available at:https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics. Accessed November 29, 2021."},{"key":"10.1016\/j.amjmed.2022.03.019_bib0074","unstructured":"U.S. Food & Drug Administration (FDA). FDA Drug Safety Communication: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Available at:https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics. Accessed November 29, 2021."}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322002467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322002467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:28:18Z","timestamp":1757582898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934322002467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0002934322002467"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.03.019","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Top Myths of Diagnosis and Management of Infectious Diseases in Hospital Medicine","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}